(Q40102767)

17 September 2017

1 reference

title

An assessment of antiviral drugs for the management of infectious diseases in humans (English)

1 reference

17 September 2017

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

21 August 2023

author name string

G. J. Galasso

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6175275

21 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6175275

21 August 2023

publication date

1 June 1981

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0166354281900358?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

https://api.elsevier.com/content/article/PII:0166354281900358?httpAccept=text/plain

21 August 2023

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

21 August 2023

1 reference

17 September 2017

1

1 reference

17 September 2017

2

1 reference

17 September 2017

73-96

1 reference

Isoprimosine in subacute sclerosing panencephalitis

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

The New England Journal of Medicine

21 August 2023

2

292

600

the NIAID-Sponsored Cooperative Antiviral Clinical Study

publication date

1975

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

The Recurrence of Herpetic Keratitis Following Idoxuridine Therapy

21 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Effects of ascorbic acid on the common cold. An evaluation of the evidence

21 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections

21 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster

21 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Inhibition of Rhinovirus Replication in Organ Culture by a Potential Antiviral Drug

21 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Successful treatment of enterovirus-infected mice by 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine

21 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Inosiplex for Localized Herpes Zoster in Childhood Cancer Patients: Preliminary Controlled Study

21 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Antiviral Activity of Intranasally Applied Human Leukocyte Interferon

21 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: A controlled study

21 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Effects of Interferon and Adenine Arabinoside Treatment of Hepatitis B Virus Infection on Cellular Immune Responses

21 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Inhibition of the multiplication of enveloped RNA-viruses by glucosamine and 2-deoxy-D-glucose

21 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

IDU therapy of herpes simplex

21 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Inhibition of rhinovirus RNA synthesis in diploid cells by a substituted guanidine compound having a different mode of action from guanidine

21 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Isoprinosine in classical acute viral hepatitis

21 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Small airways dysfunction in influenza A virus infection: therapeutic role and potential mode of action of amantadine

21 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Amantadine effect on peripheral airways abnormalities in influenza. A study in 15 students with natural influenza A infection

21 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer

21 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Inhibition of respiratory virus infection by locally applied interferon

21 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Interferon in chronic hepatitis B infection

21 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Mode of action of colistin

21 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Prevention of Reactivated Herpes Simplex Infection by Human Leukocyte Interferon after Operation on the Trigeminal Root

21 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

A Double-Blind, Controlled Trial of Levamisole in the Treatment of Recurrent Herpes Labialis

21 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Ethics in cooperative clinical trials

21 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection

21 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Trial of the antiviral action of isoprinosine against rhinovirus infection of volunteers

21 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial

21 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Rifampicin inhibits the growth of some mammalian viruses.

21 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Combination therapy of dendritic keratitis with trifluorothymidine and interferon

21 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

21 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Successful treatment of naturally occurring influenza A/USSR/77 H1N1.

21 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection

21 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Double‐blind study of interferon administration in renal transplant recipients

21 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis

21 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study

21 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Herpes simplex encephalitis: vidarabine therapy and diagnostic problems

21 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice

21 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0166-3542(81)90035-8

21 August 2023

Identifiers

1 reference

17 September 2017

1 reference